首页> 美国卫生研究院文献>The Journal of Neuroscience >Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation
【2h】

Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation

机译:苯丙胺通过恢复多巴胺转运蛋白构象逆转了可卡因摄入量的上升

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cocaine abuse disrupts dopamine system function, and reduces cocaine inhibition of the dopamine transporter (DAT), which results in tolerance. Although tolerance is a hallmark of cocaine addiction and a DSM-V criterion for substance abuse disorders, the molecular adaptations producing tolerance are unknown, and testing the impact of DAT changes on drug taking behaviors has proven difficult. In regard to treatment, amphetamine has shown efficacy in reducing cocaine intake; however, the mechanisms underlying these effects have not been explored. The goals of this study were twofold; we sought to (1) identify the molecular mechanisms by which cocaine exposure produces tolerance and (2) determine whether amphetamine-induced reductions in cocaine intake are connected to these mechanisms. Using cocaine self-administration and fast-scan cyclic voltammetry in male rats, we show that low-dose, continuous amphetamine treatment, during self-administration or abstinence, completely reversed cocaine tolerance. Amphetamine treatment also reversed escalated cocaine intake and decreased motivation to obtain cocaine as measured in a behavioral economics task, thereby linking tolerance to multiple facets of cocaine use. Finally, using fluorescence resonance energy transfer imaging, we found that cocaine tolerance is associated with the formation of DAT-DAT complexes, and that amphetamine disperses these complexes. In addition to extending our basic understanding of DATs and their role in cocaine reinforcement, we serendipitously identified a novel therapeutic target: DAT oligomer complexes. We show that dispersion of oligomers is concomitant with reduced cocaine intake, and propose that pharmacotherapeutics aimed at these complexes may have potential for cocaine addiction treatment.>SIGNIFICANCE STATEMENT Tolerance to cocaine's subjective effects is a cardinal symptom of cocaine addiction and a DSM-V criterion for substance abuse disorders. However, elucidating the molecular adaptions that produce tolerance and determining its behavioral impact have proven difficult. Using cocaine self-administration in rats, we link tolerance to cocaine effects at the dopamine transporter (DAT) with aberrant cocaine-taking behaviors. Further, tolerance was associated with multi-DAT complexes, which formed after cocaine exposure. Treatment with amphetamine deconstructed DAT complexes, reversed tolerance, and decreased cocaine seeking. These data describe the behavioral consequence of cocaine tolerance, provide a putative mechanism for its development, and suggest that compounds that disperse DAT complexes may be efficacious treatments for cocaine addiction.
机译:可卡因滥用会破坏多巴胺系统功能,并降低可卡因对多巴胺转运蛋白(DAT)的抑制作用,从而导致耐受性。尽管耐受性是可卡因成瘾的标志,并且是滥用药物障碍的DSM-V标准,但产生耐受性的分子适应机制尚不清楚,并且测试DAT变化对药物服用行为的影响已被证明是困难的。关于治疗,苯丙胺已显示出减少可卡因摄入的功效。但是,尚未探讨这些作用的潜在机制。这项研究的目标是双重的。我们试图(1)确定可卡因暴露产生耐受的分子机制,以及(2)确定苯丙胺诱导的可卡因摄入量减少是否与这些机制有关。使用可卡因自我给药和快速扫描循环伏安法在雄性大鼠中,我们显示,在自我给药或禁欲期间低剂量,连续的苯丙胺治疗完全逆转了可卡因的耐受性。苯丙胺治疗还逆转了可卡因的摄入量上升,降低了获得可卡因的行为,这是从行为经济学的角度衡量的,从而将耐受性与可卡因使用的多个方面联系起来。最后,使用荧光共振能量转移成像,我们发现可卡因耐受性与DAT-DAT复合物的形成有关,而苯丙胺分散了这些复合物。除了扩展我们对DAT及其在可卡因强化中的作用的基本理解之外,我们偶然发现了一个新的治疗靶标:DAT低聚物复合物。我们证明低聚物的分散会降低可卡因的摄入,并建议针对这些复合物的药物治疗可能具有可卡因成瘾的治疗潜力。>重要声明对可卡因的主观耐受性是可卡因成瘾的主要症状以及针对药物滥用疾病的DSM-V标准。但是,事实证明,阐明产生耐受性的分子适应性并确定其行为影响是困难的。使用大鼠中的可卡因自我管理,我们将耐受性与可卡因在多巴胺转运蛋白(DAT)上的作用与可卡因服用异常行为联系起来。此外,耐受性与可卡因暴露后形成的多DAT复合物有关。用苯丙胺治疗可解构DAT复合物,逆转耐受性并减少可卡因搜寻。这些数据描述了可卡因耐受性的行为后果,为其发展提供了可能的机制,并表明分散DAT复合物的化合物可能是可卡因成瘾的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号